Free regulatory intelligence — powered by Certivo
Substance AdditionProposedProposed RegulationSubstance Addition

Louisiana HB 152 (2026 Regular Session) proposes adding new opiate entries to Schedule I of the UCDSL

Louisiana Uniform Controlled Dangerous Substances Law (R.S. 40:961 et seq.)Louisiana State LegislatureUS, Louisiana
Announced

Mar 31, 2026

Description

Louisiana HB 152 (2026 Regular Session) is active legislative activity proposing to add new entries (opiates) to Schedule I (R.S. 40:964) of the Uniform Controlled Dangerous Substances Law, with new Schedule I entries referenced as R.S. 40:964(A)(108) through (120) in the research summary. Compliance impact: if enacted, affected substances would become Schedule I controlled substances under Louisiana law, impacting prohibited acts, enforcement exposure, and compliance programs for any entities that may handle or encounter these substances (e.g., forensic labs, healthcare/pharmacy, law enforcement evidence handling). Specific substance names and final effective date should be confirmed from the bill text/enrolled act upon enactment.

Get compliance alerts for Louisiana Uniform Controlled Dangerous Substances Law (R.S. 40:961 et seq.)

Certivo tracks regulatory changes and automates compliance workflows for your products.

Start Free Trial
Louisiana HB 152 (2026 Regular Session) proposes adding new opiate entries to Schedule I of the UCDSL | Certivo Regulations